INFLUENCE OF THE CYTOPROTECTIVE AGENT AMIFOSTINE ON TOXICITY AND PHARMACOKINETICS (PK) OF DOCETAXEL (D) IN METASTATIC BREAST-CANCER (MBC) -A FEASIBILITY STUDY OF THE EORTC-INVESTIGATIONAL DRUG BRANCH FOR BREAST-CANCER (IDBBC)

Citation
A. Awada et al., INFLUENCE OF THE CYTOPROTECTIVE AGENT AMIFOSTINE ON TOXICITY AND PHARMACOKINETICS (PK) OF DOCETAXEL (D) IN METASTATIC BREAST-CANCER (MBC) -A FEASIBILITY STUDY OF THE EORTC-INVESTIGATIONAL DRUG BRANCH FOR BREAST-CANCER (IDBBC), Annals of oncology, 9, 1998, pp. 208-208
Citations number
NO
Categorie Soggetti
Oncology
Journal title
ISSN journal
09237534
Volume
9
Year of publication
1998
Supplement
2
Pages
208 - 208
Database
ISI
SICI code
0923-7534(1998)9:<208:IOTCAA>2.0.ZU;2-Q